Pmv Pharmaceuticals, Inc. (PMVP) — 10-Q Filings
All 10-Q filings from Pmv Pharmaceuticals, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
PMVP's Losses Widen Amid Increased R&D Spend; Cash Dwindles
— Nov 12, 2025 Risk: high
PMV Pharmaceuticals, Inc. (PMVP) reported a net loss of $21.059 million for the three months ended September 30, 2025, an increase from $19.226 million for the -
PMVP Narrows Q2 Loss to $30.2M Amid R&D Spend Cuts
— Aug 7, 2025 Risk: high
PMV Pharmaceuticals, Inc. (PMVP) reported no revenue for the three and six months ended June 30, 2025, consistent with its clinical-stage status. The company po -
PMV Pharmaceuticals Files 10-Q for Q1 2025
— May 9, 2025 Risk: medium
PMV Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key financial d -
PMV Pharmaceuticals Files Q3 2024 10-Q
— Nov 7, 2024 Risk: medium
PMV Pharmaceuticals, Inc. filed its Q3 2024 10-Q report on November 7, 2024, detailing its financial performance for the period ending September 30, 2024. The c -
PMV Pharmaceuticals Files Q2 2024 10-Q
— Aug 8, 2024 Risk: medium
PMV Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its operations. Key -
PMV Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: low
PMV Pharmaceuticals, Inc. (PMVP) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. PMV Pharmaceuticals, Inc. filed a 10-Q report for the period endin
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX